ID   NLK_HUMAN               Reviewed;         527 AA.
AC   Q9UBE8; B2RCX1; Q2PNI9; Q6P2A3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 2.
DT   05-OCT-2010, entry version 94.
DE   RecName: Full=Serine/threonine-protein kinase NLK;
DE            EC=2.7.11.24;
DE   AltName: Full=Nemo-like kinase;
DE   AltName: Full=Protein LAK1;
GN   Name=NLK; Synonyms=LAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=20323218; PubMed=10863097; DOI=10.1016/S0378-1119(00)00188-8;
RA   Kehrer-Sawatzki H., Moschgath E., Maier C., Legius E., Elgar G.,
RA   Krone W.;
RT   "Characterization of the Fugu rubripes NLK and FN5 genes flanking the
RT   NF1 (Neurofibromatosis type 1) gene in the 5' direction and mapping of
RT   the human counterparts.";
RL   Gene 251:63-71(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RA   Wang C., Lo H.;
RT   "Cloning of human LAK1 cDNA.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=15004007; DOI=10.1101/gad.1166904;
RA   Ohkawara B., Shirakabe K., Hyodo-Miura J., Matsuo R., Ueno N.,
RA   Matsumoto K., Shibuya H.;
RT   "Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm
RT   induction.";
RL   Genes Dev. 18:381-386(2004).
RN   [7]
RP   INTERACTION WITH MYB AND HIPK2.
RX   PubMed=15082531; DOI=10.1101/gad.1170604;
RA   Kanei-Ishii C., Ninomiya-Tsuji J., Tanikawa J., Nomura T.,
RA   Ishitani T., Kishida S., Kokura K., Kurahashi T., Ichikawa-Iwata E.,
RA   Kim Y., Matsumoto K., Ishii S.;
RT   "Wnt-1 signal induces phosphorylation and degradation of c-Myb protein
RT   via TAK1, HIPK2, and NLK.";
RL   Genes Dev. 18:816-829(2004).
RN   [8]
RP   INTERACTION WITH RNF138 AND TCF7L2.
RX   PubMed=16714285; DOI=10.1074/jbc.M602089200;
RA   Yamada M., Ohnishi J., Ohkawara B., Iemura S., Satoh K.,
RA   Hyodo-Miura J., Kawachi K., Natsume T., Shibuya H.;
RT   "NARF, an nemo-like kinase (NLK)-associated ring finger protein
RT   regulates the ubiquitylation and degradation of T cell factor/lymphoid
RT   enhancer factor (TCF/LEF).";
RL   J. Biol. Chem. 281:20749-20760(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298 AND SER-522, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-298, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-343.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Role in cell fate determination, required for
CC       differentiation of bone marrow stromal cells. Acts downstream of
CC       MAP3K7 and HIPK2 to negatively regulate the canonical Wnt/beta-
CC       catenin signaling pathway and the phosphorylation and destruction
CC       of the MYB transcription factor. May suppress a wide range of
CC       transcription factors by phosphorylation of the coactivator,
CC       CREBBP (By similarity). Involved in TGFbeta-mediated mesoderm
CC       induction, acting downstream of MAP3K7/TAK1 to phosphorylate
CC       STAT3.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by tyrosine and threonine
CC       phosphorylation (By similarity). Activated by activin.
CC   -!- SUBUNIT: Interacts with STAT3 (By similarity). Interacts with
CC       RNF138/NARF and TCF7L2/TCF4. Interacts with HIPK2 and MYB.
CC   -!- INTERACTION:
CC       P10242:MYB; NbExp=1; IntAct=EBI-366978, EBI-298355;
CC       Q06219:Nr4a2 (xeno); NbExp=1; IntAct=EBI-366978, EBI-2337255;
CC   -!- SUBCELLULAR LOCATION: Nucleus (By similarity). Cytoplasm (By
CC       similarity). Note=Predominantly nuclear. A smaller fraction is
CC       cytoplasmic (By similarity).
CC   -!- PTM: Dually phosphorylated on Thr-303 and Tyr-305, which activates
CC       the enzyme (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD56013.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=AAF04857.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=ABC40748.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=BAG37718.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF197898; AAF04857.1; ALT_INIT; mRNA.
DR   EMBL; AF180819; AAD56013.1; ALT_INIT; mRNA.
DR   EMBL; AK315315; BAG37718.1; ALT_INIT; mRNA.
DR   EMBL; DQ316259; ABC40748.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC064663; AAH64663.2; -; mRNA.
DR   IPI; IPI00936281; -.
DR   RefSeq; NP_057315.3; -.
DR   UniGene; Hs.208759; -.
DR   ProteinModelPortal; Q9UBE8; -.
DR   IntAct; Q9UBE8; 13.
DR   MINT; MINT-2873487; -.
DR   STRING; Q9UBE8; -.
DR   PhosphoSite; Q9UBE8; -.
DR   PRIDE; Q9UBE8; -.
DR   Ensembl; ENST00000262393; ENSP00000262393; ENSG00000087095.
DR   Ensembl; ENST00000407008; ENSP00000384625; ENSG00000087095.
DR   GeneID; 51701; -.
DR   KEGG; hsa:51701; -.
DR   CTD; 51701; -.
DR   GeneCards; GC17P026369; -.
DR   H-InvDB; HIX0013640; -.
DR   HGNC; HGNC:29858; NLK.
DR   HPA; HPA018192; -.
DR   MIM; 609476; gene.
DR   PharmGKB; PA134914500; -.
DR   eggNOG; prNOG06633; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q9UBE8; -.
DR   OMA; CKCCYTT; -.
DR   OrthoDB; EOG9577RS; -.
DR   PhylomeDB; Q9UBE8; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; wnt_canonical_pathway; Canonical Wnt signaling pathway.
DR   Pathway_Interaction_DB; wnt_calcium_pathway; Noncanonical Wnt signaling pathway.
DR   Pathway_Interaction_DB; ps1pathway; Presenilin action in Notch and Wnt signaling.
DR   ArrayExpress; Q9UBE8; -.
DR   Bgee; Q9UBE8; -.
DR   CleanEx; HS_NLK; -.
DR   Genevestigator; Q9UBE8; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0004707; F:MAP kinase activity; ISS:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; ISS:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0030178; P:negative regulation of Wnt receptor signali...; ISS:UniProtKB.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045449; P:regulation of transcription; ISS:UniProtKB.
DR   GO; GO:0033136; P:serine phosphorylation of STAT3 protein; ISS:UniProtKB.
DR   GO; GO:0006350; P:transcription; IEA:UniProtKB-KW.
DR   GO; GO:0007179; P:transforming growth factor beta receptor si...; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase; Wnt signaling pathway.
FT   CHAIN         1    527       Serine/threonine-protein kinase NLK.
FT                                /FTId=PRO_0000186336.
FT   DOMAIN      138    427       Protein kinase.
FT   NP_BIND     144    152       ATP (By similarity).
FT   COMPBIAS     22     25       Poly-Ala.
FT   COMPBIAS     27     34       Poly-His.
FT   COMPBIAS     42     48       Poly-His.
FT   COMPBIAS     71     83       Poly-Ala.
FT   COMPBIAS    106    111       Poly-Ala.
FT   COMPBIAS    115    119       Poly-Ala.
FT   ACT_SITE    264    264       Proton acceptor (By similarity).
FT   BINDING     167    167       ATP (By similarity).
FT   MOD_RES     298    298       Phosphothreonine.
FT   MOD_RES     303    303       Phosphothreonine (By similarity).
FT   MOD_RES     305    305       Phosphotyrosine (By similarity).
FT   MOD_RES     522    522       Phosphoserine.
FT   VARIANT     177    177       V -> A (in dbSNP:rs11871287).
FT                                /FTId=VAR_019549.
FT   VARIANT     343    343       A -> T (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042273.
FT   CONFLICT     25     25       A -> T (in Ref. 5; AAH64663).
SQ   SEQUENCE   527 AA;  58283 MW;  CE6AEBA7D8133989 CRC64;
     MSLCGARANA KMMAAYNGGT SAAAAGHHHH HHHHLPHLPP PHLHHHHHPQ HHLHPGSAAA
     VHPVQQHTSS AAAAAAAAAA AAAMLNPGQQ QPYFPSPAPG QAPGPAAAAP AQVQAAAAAT
     VKAHHHQHSH HPQQQLDIEP DRPIGYGAFG VVWSVTDPRD GKRVALKKMP NVFQNLVSCK
     RVFRELKMLC FFKHDNVLSA LDILQPPHID YFEEIYVVTE LMQSDLHKII VSPQPLSSDH
     VKVFLYQILR GLKYLHSAGI LHRDIKPGNL LVNSNCVLKI CDFGLARVEE LDESRHMTQE
     VVTQYYRAPE ILMGSRHYSN AIDIWSVGCI FAELLGRRIL FQAQSPIQQL DLITDLLGTP
     SLEAMRTACE GAKAHILRGP HKQPSLPVLY TLSSQATHEA VHLLCRMLVF DPSKRISAKD
     ALAHPYLDEG RLRYHTCMCK CCFSTSTGRV YTSDFEPVTN PKFDDTFEKN LSSVRQVKEI
     IHQFILEQQK GNRVPLCINP QSAAFKSFIS STVAQPSEMP PSPLVWE
//
